The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_177438.3(DICER1):c.1904A>G (p.Asn635Ser)

CA7331374

479636 (ClinVar)

Gene: DICER1
Condition: dicer1 syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: e91d9267-aede-4514-ba57-8eb86a59b69b
Approved on: 2022-10-25
Published on: 2022-11-03

HGVS expressions

NM_177438.3:c.1904A>G
NM_177438.3(DICER1):c.1904A>G (p.Asn635Ser)
NC_000014.9:g.95115670T>C
CM000676.2:g.95115670T>C
NC_000014.8:g.95582007T>C
CM000676.1:g.95582007T>C
NC_000014.7:g.94651760T>C
NG_016311.1:g.46753A>G
ENST00000343455.8:c.1904A>G
ENST00000393063.6:c.1904A>G
ENST00000526495.6:c.1904A>G
ENST00000532939.3:c.1904A>G
ENST00000556045.6:c.1904A>G
ENST00000675995.1:c.*220A>G
ENST00000343455.7:c.1904A>G
ENST00000393063.5:c.1904A>G
ENST00000526495.5:c.1904A>G
ENST00000527414.5:c.1904A>G
ENST00000532458.1:n.493A>G
ENST00000541352.5:c.1904A>G
NM_001195573.1:c.1904A>G
NM_001271282.2:c.1904A>G
NM_001291628.1:c.1904A>G
NM_030621.4:c.1904A>G
NM_177438.2:c.1904A>G
NM_001271282.3:c.1904A>G
NM_001291628.2:c.1904A>G
NM_001395677.1:c.1904A>G
NM_001395678.1:c.1904A>G
NM_001395679.1:c.1904A>G
NM_001395680.1:c.1904A>G
NM_001395682.1:c.1904A>G
NM_001395683.1:c.1904A>G
NM_001395684.1:c.1904A>G
NM_001395685.1:c.1904A>G
NM_001395686.1:c.1622A>G
NM_001395687.1:c.1499A>G
NM_001395688.1:c.1499A>G
NM_001395689.1:c.1499A>G
NM_001395690.1:c.1499A>G
NM_001395691.1:c.1337A>G
NM_001395692.1:c.1904A>G
NM_001395693.1:c.1904A>G
NM_001395694.1:c.1904A>G
NM_001395695.1:c.1904A>G
NM_001395696.1:c.1499A>G
NM_001395697.1:c.221A>G
NM_001395698.1:c.1499A>G
NR_172715.1:n.2322A>G
NR_172716.1:n.2249A>G
NR_172717.1:n.2416A>G
NR_172718.1:n.2416A>G
NR_172719.1:n.2249A>G
NR_172720.1:n.2249A>G

Uncertain Significance

The Expert Panel has overridden the computationally generated classification - "[unknown]"
Not Met criteria codes 18
BA1 BP2 BP4 BP7 BS2 BS4 BS3 BS1 PP4 PP1 PP3 PM2 PM1 PM5 PS2 PS4 PS3 PS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen DICER1 and miRNA-Processing Gene Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for DICER1 Version 1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
DICER1 and miRNA-Processing Gene VCEP
The NM_177438.2:c.1904A>G variant in DICER1 is a missense variant predicted to cause substitution of Aspartic Acid by Serine at amino acid 635 (p.Asp635Ser). This variant received 0 phenotype points across 16 probands, including 3 unrelated females without tumors through age 50 (GTRs: 61756, 500031, PMID: 33718253) (PS4 and BS2 are not met). The highest population minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.00003 (1/30526 alleles) in South Asian population (PM2_Supporting, BS1, and BA1 are not met). The computational predictor REVEL gives a score of 0.398, which is below the threshold of 0.5; however, the splice site predictors MaxEntScan and SpliceAI indicate creation of a new donor splice site (BP4 and PP3 not met). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1 syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: No criteria. (Bayesian Points: 0; VCEP specifications version 1.1.0; 10/25/2022).
Not Met criteria codes
BA1
The highest population minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.00003 (1/30526 alleles) in South Asian population (PM2_Supporting, BS1, and BA1 are not met).
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
The computational predictor REVEL gives a score of 0.398, which is below the threshold of 0.5, but the splice site predictors MaxEntScan and SpliceAI indicate a new donor splice site is created that may compete with the native donor splice site (BP4 and PP3 not met). REVEL = 0.398 < 0.5 SpliceAI Donor Gain = 0.84 (no loss of native donor) MaxEntScan native donor = 7.37, 7.37; new donor = 0, 4.29
BP7
Missense variant
BS2
This variant has been seen in 3 unrelated females without tumors through age 50 in at least one testing laboratory
BS4
No segregation info
BS3
No experimental data found
BS1
The highest population minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.00003 (1/30526 alleles) in South Asian population (PM2_Supporting, BS1, and BA1 are not met).
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No segregation info
PP3
The computational predictor REVEL gives a score of 0.398, which is below the threshold of 0.5, but the splice site predictors MaxEntScan and SpliceAI indicate a new donor splice site is created that may compete with the native donor splice site (BP4 and PP3 not met). REVEL = 0.398 < 0.5 SpliceAI Donor Gain = 0.84 (no loss of native donor) MaxEntScan native donor = 7.37, 7.37; new donor = 0, 4.29
PM2
The highest population minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.00003 (1/30526 alleles) in South Asian population (PM2_Supporting, BS1, and BA1 are not met).
PM1
This variant does not reside within a region of the RNAse IIIb domain that is defined as a mutational hotspot or critical functional domain by the ClinGen DICER1 VCEP (PM1 not met).
PM5
None observed
PS2
No info
PS4
This variant received 0 phenotype points across 16 probands.
PS3
No experimental data found
PS1
None observed
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.